Baruch Blumberg: Science on TV

For cancer researcher and medical historian Baruch S. Blumberg, communication is central element in the scientific enterprise This month, many Americans will see him in that role when public television station across the country broadcast "Plagues." A host of the one-hour program, Blumberg traces the origins of several deadly epidemics: malaria, which may have contributed to as many as half of all human deaths to date the 1849 outbreak of cholera in London; the 1918 Spanish flu; and Legionnair

Written byPeter Gwynne
| 12 min read

Register for free to listen to this article
Listen with Speechify
0:00
12:00
Share

Blumberg, vice president for population oncology and senior member of the Institute for Cancer Research at Fox Chase Cancer Center in Philadelphia, is also professor of medicine and anthropology at the University of Pennsylvania. He received his M.D. from Columbia University College of Physicians and Surgeons in 1951 and his Ph.D. in biochemistry from Oxford University in 1957. He shared the 1976 Nobel prize in medicine and physiologyfor his role in identifying the Australian antigen in human blood and discovering its association with serum hepatitis—a development that led to a dramatic reduction in the transmission of hepatitis B through bload transfusions.

Blumberg was intervicwed March 24 by Peter Gwynne, director of editorial operations of THE SCIENTIST. This is an edited version of their talk.

In "Plague you talk about the Daedalus Effect, that a solution to a problem often creates new problems by is very existence, and the new problem ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies